The Effect of Phacoemulsification on the Macular Changes in Patients with Neovascular Age-related Macular Degeneration
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50+
SponsorAssiut University
About this trial
The macula has a very high concentration of photoreceptor cells - the cells that detect light. They send signals to the brain, which interprets them as images. The rest of the retina processes our peripheral, or side vision To explore whether cataract surgery evokes development or relapse of choroidal neovascularization (CNV) in wet age-related macular degeneration (AMD) patients followed for a 1-year postoperative period
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Above 50 years old
not diabetic individuals
wet ARMD
Disqualifiers
intraoperative complications
Eyes with diseases predisposing them for postoperative macular edema, preexisting macular edema, and eyes that developed cystoid macular edema
active ocular inflammation or infection _glaucoma
A preoperatively worsened VA regardless phE
Trial population
old age population had phacoemulsefcation with history of neovascular AMD
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
To figure out the possibility of Postoperative conversion or relapse ( Dry to wet , wet to reactivated CNV)
To explore whether cataract surgery evokes development or relapse of choroidal neovascularization (CNV) in wet age-related macular degeneration (AMD) patients followed for a 1-year postoperative period
Time frame
baselineLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: